HIV Research

North American and African clinical trials led by Scripps Research, IAVI, and additional collaborators across the US and Africa mark progress toward an effective HIV vaccine

Dr. Obiageli Okafor discusses growing resistance to dolutegravir and the need for global access to affordable HIV treatment and prevention

The new test panel provides a single-tube, 2.5-hour workflow designed to enable detection down to 1,000 viral genome copies

The findings shed light on how sugar molecules in the blood of people living with HIV may have pro-inflammatory effects

Trial reveals the need for more accurate screening in Black people and cisgender women

This global project aims to discover an HIV vaccine that is practical for those in low-resource countries

Intradermally administering JYNNEOS vaccine induces an efficient immune response against mpox in people with HIV-1 infection

NIH leadership calls for population-specific considerations in study design